China FDA Orders Hep B Vaccine Suspended After Two Infant Deaths
This article was originally published in PharmAsia News
Executive Summary
The China FDA ordered use of two batches of a hepatitis B vaccine suspended after it was blamed for the deaths of two infants in Hunan Province.